LAI
MRNA icon

Legal Advantage Investments’s Moderna MRNA Stock Holding History

Legal Advantage Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.34M Sell
47,675
-500
-1% -$25.9K 1.17% 26
2026
Q1 		$2.45M Hold
48,175
– – 1.26% 31
2025
Q4 		$1.42M Hold
48,175
– – 0.66% 41
2025
Q3 		$1.24M Buy
+48,175
New +$1.34M 0.56% 46

Other funds holding MRNA

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Legal Advantage Investments's MRNA Position: Q2 2026 in Review

Legal Advantage Investments reduced its Moderna (MRNA) stake by 1% in Q2 2026, selling an estimated $25.9K and leaving 47,675 shares worth $3.34M. The position accounts for 1.17% of the portfolio, ranked #26.

Legal Advantage Investments first reported a position in MRNA in Q3 2025 and has held it in 4 quarters since. 288 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Legal Advantage Investments held 47,675 shares of Moderna worth $3.34M as of Q2 2026.
  • Legal Advantage Investments sold 500 Moderna shares in Q2 2026, an estimated $25.9K.
  • Moderna made up 1.17% of Legal Advantage Investments's portfolio in Q2 2026, its #26 holding.
  • Legal Advantage Investments first reported a position in Moderna in Q3 2025 and has held it in 4 quarters since.
  • 288 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Legal Advantage Investments's 13F filing for Q2 2026, filed 15 Jul 2026.